FORCE Blog

This blog will cover topics of interest that affect our community. Unless otherwise stated, the blog articles will be written by Sue Friedman, Executive Director of FORCE.

| More

Metastatic breast cancer

July 15, 2019

Breast Cancer Patients Need More Information on Precision Medicine, Tumor Testing and Genetics

by Sue Friedman (FORCE) with Janine Guglielmino (LBBC) When people are diagnosed with cancer, doctors perform tests to learn more about the cancer and the best way to treat it. Ongoing advances in medicine are making it possible for  doctors to look at the unique makeup of each patient and their tumor to choose the … + read more

April 12, 2018

PARP Inhibitors and Hereditary Cancer: What’s New?

by Sue Friedman PARP inhibitors are drugs designed specifically to treat cancers in people with certain inherited mutations, including BRCA1 and BRCA2, among others. These drugs block an enzyme – known as PARP – used by cells to repair damage to their DNA. Although these agents seem to be most effective in people with mutations—not just … + read more

February 22, 2018

FORCE Participates in The Metastatic Breast Cancer Alliance

by Diane Rose There are large gaps in research, support, information, advocacy and resources for people with advanced breast cancer. People with metastatic breast cancer who also have an inherited mutation like BRCA or PALB2 face additional challenges associated with children and other relatives sharing the same hereditary cancer risk. The Metastatic Breast Cancer Alliance … + read more

February 11, 2013

Progress in Hereditary Cancer Treatment Research

Recently I participated in the Gynecologic Oncology Group (GOG) semi-annual meeting in San Diego. The GOG is part of the National Cancer Institute’s Clinical Trials Cooperative Group Program, whose role is to promote and support clinical trials for cancers. As one of the members of the Patient Advocacy Committee of GOG I participate by providing the consumer perspective and … + read more

December 12, 2012

Clinical Trials for Hereditary Cancer: Where the Rubber Meets the Road

This blog is a call to action! Please read on, and then post, blog, tweet, retweet, and share about this issue so that we can assure that hereditary cancer research continues! The call for more research is a constant theme for all diseases including cancer, and sometimes it’s easy to get frustrated by the slow pace … + read more

July 12, 2011

Prioritizing research for metastatic hereditary cancer

There is a need for more treatment options for hereditary cancer, and the need is dire for women with metastatic hereditary breast cancer who make up a small subset of the larger breast cancer population. To better understand advanced hereditary breast cancer and to advocate for more research and better treatment options, FORCE conducted a … + read more

Connect with others.

Call our Helpline

Our helpline offers peer support for people concerned about hereditary cancer. All calls are confidential. Call any time.

Join a Local Group

FORCE has outreach groups throughout the United States and in Essex, United Kingdom that meet periodically to offer peer support, and share resources.

FORCE:Facing Our Risk of Cancer Empowered